1. Home
  2. RNST vs EVO Comparison

RNST vs EVO Comparison

Compare RNST & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNST
  • EVO
  • Stock Information
  • Founded
  • RNST 1904
  • EVO 1993
  • Country
  • RNST United States
  • EVO Germany
  • Employees
  • RNST N/A
  • EVO N/A
  • Industry
  • RNST Major Banks
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RNST Finance
  • EVO Health Care
  • Exchange
  • RNST Nasdaq
  • EVO Nasdaq
  • Market Cap
  • RNST 3.3B
  • EVO 1.5B
  • IPO Year
  • RNST N/A
  • EVO 2021
  • Fundamental
  • Price
  • RNST $37.76
  • EVO $4.20
  • Analyst Decision
  • RNST Buy
  • EVO Buy
  • Analyst Count
  • RNST 6
  • EVO 2
  • Target Price
  • RNST $42.20
  • EVO $5.90
  • AVG Volume (30 Days)
  • RNST 531.4K
  • EVO 114.3K
  • Earning Date
  • RNST 07-22-2025
  • EVO 08-13-2025
  • Dividend Yield
  • RNST 2.33%
  • EVO N/A
  • EPS Growth
  • RNST 31.26
  • EVO N/A
  • EPS
  • RNST 3.20
  • EVO N/A
  • Revenue
  • RNST $710,265,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • RNST $40.84
  • EVO $10.08
  • Revenue Next Year
  • RNST $13.45
  • EVO $10.99
  • P/E Ratio
  • RNST $11.80
  • EVO N/A
  • Revenue Growth
  • RNST 15.97
  • EVO 1.50
  • 52 Week Low
  • RNST $26.97
  • EVO $2.84
  • 52 Week High
  • RNST $39.63
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • RNST 56.90
  • EVO 52.95
  • Support Level
  • RNST $37.38
  • EVO $4.04
  • Resistance Level
  • RNST $39.27
  • EVO $4.26
  • Average True Range (ATR)
  • RNST 0.84
  • EVO 0.11
  • MACD
  • RNST 0.12
  • EVO -0.01
  • Stochastic Oscillator
  • RNST 58.94
  • EVO 51.61

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: